Abbott Laboratories to Pay $385 Million in Settlement Over Baby Formula Plant Contamination
publishers 2articles 2first reported 14 Sep, 18:08 UTCdeveloping since 15 Sep · 2 editions
Abbott Laboratories has agreed to pay $385 million to settle allegations related to the operation of a manufacturing plant in Michigan, which was linked to contaminated powdered infant formula. The settlement resolves claims brought by the Justice Department in connection with the 2022 recall of several infant formula brands, including Similac, following contamination concerns. According to The Hill, the contamination was suspected of causing infant deaths and led to the temporary closure of the nation's largest formula facility. ABC News reports that the settlement addresses claims tied to an investigation and lawsuit involving Abbott's manufacturing practices and the 2022 recall. The incident exacerbated existing supply chain challenges in the infant formula market. No further details about the settlement terms or specific allegations were provided by the sources.
HOW THIS STORY WAS MADE
Written from 2 articles, 1 with the publisher's own text; 2 independent newsrooms once syndicated copies count as one.
- Publishers
- 2
- Source articles
- 2
- Given to the writer
- 2, 1 with the article's own text
- Independent newsrooms
- 2
- Publication gate
- passed
- Human review
- none
Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →